|
|
Improving T-cell therapies for neuroblastoma
|
5R01CA142636-04
|
$366,494
|
$183,247
|
DOTTI, GIANPIETRO
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Enhancing T Cell Therapy of Cancer
|
2P01CA094237-11
|
$1,932,287
|
$1,932,287
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
$8,250
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
$4,759
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
$340,209
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Engineered tumor-specific T cells Resist Hypoxic-Tumor Immunosuppressive Attacks.
|
5R01CA142664-04
|
$290,421
|
$72,605
|
YOTNDA, PATRICIA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
A prospective analysis of peripheral blood cytokines and non-Hodgkin lymphoma
|
5R01CA149445-03
|
$560,228
|
$560,228
|
BIRMANN, BRENDA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB
|
5K08CA140780-04
|
$179,910
|
$179,910
|
Gewurz, Benjamin
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-14
|
$363,204
|
$363,204
|
Kaye, Kenneth
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Roles of Epstein-Barr virus nuclear antigens 2 and LP in B cell proliferation
|
1R01CA170023-01A1
|
$365,632
|
$365,632
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Epstein-Barr Virus Nuclear Protein in B Cell Growth Transformation
|
5R01CA047006-26
|
$531,318
|
$531,318
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Epstein-Barr Virus LMP1-Mediated Oncogenecity
|
5R01CA085180-12
|
$659,320
|
$659,320
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
|
5R01CA131354-05
|
$337,720
|
$337,720
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Pathogenesis of EBV Infection
|
5R01CA068051-18
|
$423,802
|
$423,802
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
|
6R01CA098285-10
|
$457,564
|
$457,564
|
ALT, FREDERICK
|
CHILDREN'S HOSPITAL CORPORATION
|
|
|
Control of CMV infection post-HCT using attenuated MVA-based CMV subunit vaccine
|
5R01CA077544-12
|
$84,049
|
$84,049
|
Diamond, Don
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
City of Hope Lymphoma SPORE
|
5P50CA107399-08
|
$2,150,500
|
$64,515
|
Forman, Stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
2P30CA033572-30
|
$2,042,489
|
$40,850
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-30S1
|
$125,000
|
$2,500
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-30S2
|
$52,354
|
$1,047
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-30S3
|
$10,680
|
$214
|
FRIEDMAN, MICHAEL
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Evaluating New Targets of CMV Cellular Immunity
|
5R01CA145207-08
|
$369,551
|
$369,551
|
Zaia, John
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Antiviral actions of interferons
|
5R01CA068782-26
|
$409,382
|
$135,096
|
SEN, GANES
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
|
Complementary Signaling Pathways In Hodgkin Lymphoma and Related Malignancies
|
5R01CA161026-03
|
$402,341
|
$100,585
|
SHIPP, MARGARET
|
DANA-FARBER CANCER INST
|
|
|
Cancer Center Support Grant
|
3P30CA023108-35S1
|
$12,500
|
$250
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant
|
3P30CA023108-35S2
|
$50,000
|
$1,000
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Cancer Center Support Grant
|
5P30CA023108-35
|
$2,922,577
|
$58,452
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
|
Immune surveillance in murine gammaherpesvirus infection
|
5R01CA103642-10
|
$259,585
|
$259,585
|
Usherwood, Edward
|
DARTMOUTH COLLEGE
|
|
|
Duke Comp Cancer Inst. Core Support Grant
|
3P30CA014236-39S1
|
$18,744
|
$187
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
|
Duke Comp Cancer Inst. Core Support Grant
|
5P30CA014236-39
|
$5,351,774
|
$53,518
|
KASTAN, MICHAEL
|
DUKE UNIVERSITY
|
|
|
Host pathways regulating Epstein-Barr virus-mediated B cell growth transformation
|
5R01CA140337-03
|
$306,229
|
$306,229
|
Luftig, Micah
|
DUKE UNIVERSITY
|
|
|
Temporal regulation of the essential Epstein-Barr virus oncoprotein LMP1
|
1F31CA180451-01
|
$32,501
|
$32,501
|
Price, Alexander
|
DUKE UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-05S2
|
$37,430
|
$1,123
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-05
|
$1,396,397
|
$41,892
|
Curran, Walter
|
EMORY UNIVERSITY
|
|
|
Control of Gammaherpesvirus Replication
|
5R01CA052004-24
|
$291,916
|
$291,916
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
|
Role of B Cells in Murine Gammaherpesvirus-68 Latency
|
5R01CA095318-09
|
$310,947
|
$310,947
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
|
Impact of HIV and HHV-8 Co-Infection on Antiretroviral Therapy Efficacy in Africa
|
5R01CA138165-04
|
$282,976
|
$282,976
|
CASPER, COREY
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S1
|
$109,383
|
$1,094
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S2
|
$18,750
|
$188
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S3
|
$125,000
|
$1,250
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
3P30CA015704-39S4
|
$50,000
|
$500
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Cancer Center Support Grant (Comprehensive)
|
5P30CA015704-39
|
$10,072,717
|
$100,727
|
Corey, Lawrence
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Human Herpesvirus-8 Replication and Kaposi Sarcoma Response to Treatment
|
5K23CA150931-03
|
$142,429
|
$142,429
|
Phipps, Warren
|
FRED HUTCHINSON CAN RES CTR
|
|
|
Gene-environment EBV Interactions in the Etiology of Nasopharyngeal Carcinoma (NP
|
5R01CA115873-06
|
$412,611
|
$412,611
|
ADAMI, HANS-OLOV
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
|
Characterization of ER-localized Activity of HHV-8 Interleukin-6
|
5F31CA171933-02
|
$42,232
|
$42,232
|
Cousins, Emily
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Targeting Kinases that Phosphorylate the KSHV LANA Chromatin Binding Domain
|
5R21CA171814-02
|
$165,605
|
$165,605
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Regional Oncology Research Center
|
3P30CA006973-50S1
|
$43,750
|
$875
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Regional Oncology Research Center
|
3P30CA006973-50S2
|
$50,000
|
$1,000
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Regional Oncology Research Center
|
5P30CA006973-50
|
$6,540,575
|
$130,812
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Inhibitory targeting of HHV-8 vIL-6-related interactions.
|
1R21CA171937-01A1
|
$176,175
|
$176,175
|
Nicholas, John
|
JOHNS HOPKINS UNIVERSITY
|
|
Total relevant funding to Herpes - Other for this search: $44,100,443
|
